# Major Recall Alert: Unauthorized and Counterfeit Health Products Seized at Thumbs Up 4 Shiatsu in Mississauga, Ontario
**Bepanthen, Bepacto, Biacto, Mounjaro (tirzepatide) Products, and More Under Recall**
Health Canada has issued a critical warning to consumers about the seizure of multiple unauthorized and counterfeit health products at Thumbs Up 4 Shiatsu, located in Mississauga, Ontario. These products, which include injectables such as *Bepanthen (Dekspantenol 500 mg/2 ml), Bepacto (Dexpanthenol 500 mg/2 ml), Biacto (Biotin 5 mg/1 ml), Mounjaro vials and KwikPens (tirzepatide injections), Tofacitinib Tablets IP 5 mg, Rhofanib 5 (Tofacitinib 5 mg), and Haircare from Laboratoire Revitacare France (Hyaluronic acid 2 mg)*, have **not been authorized by Health Canada.**
Counterfeit drugs can pose significant health risks to consumers, as they are not assessed for safety, efficacy, or quality. Selling such unauthorized products is illegal under Canadian law.
---
## Why This Recall is Important
The recent seizure underscores the dangerous consequences of circulating counterfeit or unauthorized health products, especially those marketed for cosmetic or medical purposes like pain management, hair loss, or weight control.
Key concerns include:
- **Unverified safety**: Products like *Mounjaro vials and KwikPens (DIN 03552000, batch D856216)* were confirmed counterfeit by their manufacturer.
- **Unknown ingredients**: These products may not contain the active pharmaceutical ingredient (API) or could include harmful contaminants.
- **Public health risks**: Fake prescription injectables can lead to infections, scarring, allergic reactions, and other severe adverse effects.
It’s alarming that some counterfeit products mimic legitimate items, even including false DINs to mislead consumers into thinking they are authorized.
---
## Details of the Recall
Here are the health products affected by the Health Canada recall:
- **Bepanthen** (*Dekspantenol 500 mg/2 ml*)
- **Bepacto** (*Dexpanthenol 500 mg/2 ml*)
- **Biacto** (*Biotin 5 mg/1 ml*)
- **Mounjaro vials** and **Mounjaro KwikPens** (*tirzepatide injection*)
- DIN: 03552000 (invalid), Batch: D856216 (confirmed counterfeit)
- **Tofacitinib Tablets IP 5 mg**
- **Rhofanib 5** (*Tofacitinib 5 mg*)
- **Haircare** by Laboratoire Revitacare France (*Hyaluronic acid 2 mg*)
**Risks of Unauthorized Products**
- Dangerous interactions with other medications.
- Excessive or insufficient active ingredients.
- High-risk ingredients, contaminants, or hidden additives.
- Unsafe manufacturing or storage conditions.
The products were likely used or sold for medical and cosmetic treatments, including injectables for weight loss, pain relief, and hair regrowth—raising risks for unsuspecting consumers.
---
## What You Should Do
Protect yourself by taking the following steps:
1. **Stop using the products immediately**: If you purchased or received treatments with any products listed above, discontinue usage.
2. **Seek medical advice**: If you have health concerns linked to these products, consult your healthcare provider immediately.
3. **Report to Health Canada**: Notify any adverse events or illegal sales to Health Canada.
4. **Verify your prescriptions**: Only purchase prescription drugs from licensed pharmacies and follow health professionals' advice.
Visit the official [Health Canada Recall Notice](https://recalls-rappels.canada.ca/en/alert-recall/unauthorized-and-counterfeit-health-products-seized-thumbs-4-shiatsu-mississauga-may) for more details.
---
## Stay Safe – Get Instant Recall Alerts
The safety of your health products starts with awareness. To avoid counterfeit or unsafe treatments, ensure your medications are from trusted, licensed sources. Stay informed about recalls and protect your loved ones from dangerous products.
**Download the Official Recalls Canada App** for instant updates on health product recalls. Knowledge is your best defense!
[Official Health Canada Source](https://recalls-rappels.canada.ca/en/alert-recall/unauthorized-and-counterfeit-health-products-seized-thumbs-4-shiatsu-mississauga-may)